Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04558775 · ClinicalTrials.gov registry record
TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 418
- Enrollment target
NCT04558775 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 418 participants.
The verdict
NCT04558775 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 418 participants
- Enrollment target
Study Summary
This is a multicenter study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict DFU wound recurrence. Trans-epidermal water loss (TEWL) will be measured on the closed wound site and a location similar to the wound site (reference site). Participants will be enrolled within two weeks after closure of their DFU. Complete wound healing will be verified at a second visit two weeks later and this visit will start the 16 week timeline where participants will be followed weekly by phone until the earliest of DFU wound recurrence or 16 weeks. Participants who experience a DFU wound recurrence and a subset of participants who do not experience a DFU wound recurrence by week 16 will be asked to attend one final visit.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2020-06-17 |
| Est. Completion | 2022-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04558775
The ClinicalTrials.gov registry entry for NCT04558775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 418 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT04558775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04558775 about?
NCT04558775 is a clinical study titled "TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence". This is a multicenter study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict DFU wound recurrence. Trans-epidermal water loss (TEWL) will be measured on the closed wound site and a location similar to the wound site (reference site). ...
What is the current status of trial NCT04558775?
This trial is currently completed. The enrollment target is 418 participants. The study started on 2020-06-17. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04558775?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04558775?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.